Pharmaust Limited (AU:NUZ) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neurizon Therapeutics Limited is set to host a webinar on December 12, 2024, offering insights into its progress and future plans in treating neurodegenerative diseases, particularly ALS. The company aims to accelerate access to effective treatments through international collaborations and robust clinical trials. Investors and interested parties can participate in the webinar and access recorded sessions on the Neurizon Investor Hub.
For further insights into AU:NUZ stock, check out TipRanks’ Stock Analysis page.